We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » “No Actual Negotiation” in IRA, Says AstraZeneca in Motion to Strike Down Law
“No Actual Negotiation” in IRA, Says AstraZeneca in Motion to Strike Down Law
Around the same time AstraZeneca was signing its price negotiation agreement with CMS for its diabetes drug Farxiga, which is included in the Inflation Reduction Act’s (IRA) first list of Medicare Part D high cost drugs, the company was also filing a motion for summary judgment for the courts to declare the IRA unconstitutional.